Acabas de hacer clic en un enlace para ir a otro sitio web. Si continúas, es posible que vayas a un sitio que no nos pertenece.
Nosotros no revisamos ni controlamos el contenido de los sitios que no son de Medtronic, ni somos responsables de ninguna actividad o transacción comerciales que realices en ellos. Tu uso del otro sitio está sujeto a las condiciones de uso y la declaración de privacidad de ese sitio.
Es posible que algunos de los productos en el otro sitio no estén aprobados en tu región o país.
Tu navegador está desactualizado
Con un navegador actualizado, tendrás una mejor experiencia en el sitio web de Medtronic. Actualizar mi navegador ahora.
La información de esta sección está dirigida exclusivamente al profesional sanitario residente en España facultado para prescribir o dispensar medicamentos, puesto que se requiere una formación especializada para su correcta interpretación.
Al aceptar, confirma que usted es un profesional sanitario.
Bob White is Executive Vice President and President, Medical Surgical Portfolio for Medtronic. Based in Boulder, Colorado, he is a member of the Medtronic Executive Committee.
Since 2017, Bob has served as Executive Vice President and Group President of the Medtronic Minimally Invasive Therapies Group of Medtronic, a $9 billion business with three global business units of 25,000 employees across 70 countries.
Before then, Bob was Senior Vice President and President of Medtronic Asia Pacific based in Singapore. Under Bob’s leadership and collaborative approach, Asia Pacific became one of the fastest growing regions within Medtronic — demonstrating a commitment to supporting healthcare systems through meaningful innovation, global access, and aligning value. Bob is invigorated by the opportunities for Medtronic to contribute to improving the lives of millions of patients around the world through the transformation of healthcare delivery.
Bob also believes in empowering employees at all levels of the organization to play an active role in fulfilling the Medtronic Mission. In 2015, following the Medtronic acquisition of Covidien, Bob successfully led the integration of the two companies across Australia and New Zealand, Southeast Asia, Indian Sub-Continent, South Korea, and Japan. Over 5,000 employees were brought together as one team to deliver technology, services, and solutions to support healthcare providers in both developed and emerging markets.
Previously, Bob has served as President, Emerging Markets, President, Respiratory and Monitoring Solutions, and Vice President and General Manager of Patient Monitoring at Covidien. He has also held leadership positions at GE Healthcare and IBM.
Bob is currently a Non-Executive Director of the Smith+Nephew Board and a Fellow of the American College of Healthcare Executives (FACHE). He was also formerly on the boards of the Asia Pacific Medical Technology Association (APACMed), the US-ASEAN Business Council, the Anesthesia Patient Safety Foundation (APSF), and the National Patient Safety Foundation (NPSF).
Bob is also the Executive Sponsor of enterprise-wide culture programs, including the Medtronic Ethical Culture Taskforce and the Medtronic Hispanic Latino Network, and he is also a member of the Executive Steering Committee for Medtronic high-potential differentiated development programs.
Bob holds a bachelor’s degree in marketing from Cleveland State University and an MBA from Case Western Reserve University.